TABLE III

Summary of Targeted Quantitation Results for Blood and Solvent Extraction Study

Targeted AnalyteConcentration of Analyte (μg/Device)
BloodSaline10% Ethanol20% Ethanol40% Ethanol70% Ethanol
Caprolactam27.34 ± 0.8321.48 ± 0.7324.18 ± 0.1724.68 ± 1.7135.04 ± 1.9231.10 ± 1.29
4-4-Methylenedianiline10.63 ± 0.071<0.102.17 ± 0.264.88 ± 0.9421.7 ± 0.9989.37 ± 10.00
Bisphenol A<10<10<100.8 ± 0.228.8 ± 4.750.5 ± 5.5
Bisphenol A
Monomethyl ether		<10<10<10<104.9 ± 0.67.6 ± 0.8
Bisphenol A
Dimethyl ether		<10<10<10<1011.8 ± 1.9296.2 ± 68.2
Di-(2-ethylhexyl) phthalate<500<100<100<100<1001161 ± 389
Trioctyltrimellitate<500<100<100<100<1003631 ± 381
Cyclohexanone<2030 ± 5154 ± 8140 ± 45269 ± 72243 ± 31
Myristic acid*elevated in background1.43 ± 0.173.04 ± 0.365.21 ± 1.2955.02 ± 6.93126.18 ± 15.88
Polyvinylpyrrolidone2<3537.3 ± 6.343.4 ± 9.626.9 ± 6.219.6 ± 5.95.9 ± 1.1

  • Samples were analyzed in triplicate. Average and standard deviation are reported.

  • ↵1 Low recovery was observed for this analyte in blood.

  • ↵2 Values are reported in mg/device.